BEDFORD, Mass., Feb. 13, 2024 Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and.
CHATHAM, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates,
When Ben Shannon and his daughter Sumire entered the Masters of Musical Whistling contest, he initially thought it would simply be a fun afternoon activity. Instead they met people from around the world who were so passionate about their craft, it made Shannon question if he’d ever allowed himself to be truly earnest about life’s endeavours.
Led by healthcare-focused institutional investors. $30 million financing upfront with up to an additional $114 million tied to the exercise of warrants. CHATHAM, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) Tonix